# Perioperative Cancer Cell Dissemination and Systemic Immune Suppression in Resectable Ductal Pancreatic Adenocarcinoma

> **NCT00495924** · — · COMPLETED · sponsor: **KU Leuven** · enrollment: 100 (estimated)

## Conditions studied

- Pancreatic Neoplasms
- Adenocarcinoma
- Neoplasm Circulating Cells
- Tumor Markers, Biological
- Monitoring, Immunologic

## Interventions

- **PROCEDURE:** Pancreatic resection (PD)

## Key facts

- **NCT ID:** NCT00495924
- **Lead sponsor:** KU Leuven
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** —
- **Final completion:** 2008-10
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2009-07-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00495924

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00495924, "Perioperative Cancer Cell Dissemination and Systemic Immune Suppression in Resectable Ductal Pancreatic Adenocarcinoma". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT00495924. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*